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Abstract
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regulatory protein. The Escherichia coli AcrR is a member of the TetR family of transcriptional regulators. It
regulates the expression of the AcrAB multidrug transporter. Recombinant AcrR with a 6×His tag at the C-
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unit-cell parameters a = b = 46.61, c = 166.16 Å.
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This paper describes the cloning, expression, purification and preliminary X-ray
data analysis of the AcrR regulatory protein. The Escherichia coli AcrR is a
member of the TetR family of transcriptional regulators. It regulates the
expression of the AcrAB multidrug transporter. Recombinant AcrR with a
6His tag at the C-terminus was expressed in E. coli and purified by metal-
affinity chromatography. The protein was crystallized using hanging-drop vapor
diffusion. X-ray diffraction data were collected from cryocooled crystals at a
synchrotron light source. The best crystal diffracted to 2.5 A˚. The space group
was determined to be P32, with unit-cell parameters a = b = 46.61, c = 166.16 A˚.
1. Introduction
The increase in bacterial resistance to multiple drugs has emerged as
a major clinical problem. One important mechanism that gives rise to
multidrug resistance (MDR) in bacteria is the expression of multi-
drug transporters, which are often regulated at the transcriptional
level by repressors and/or activators (Grkovic et al., 2001). Many of
these transcriptional factors are multi-ligand-binding proteins which
recognize the same array of toxic chemicals extruded by the trans-
porters that they regulate (Ahmed et al., 1994). These transcriptional
factors act as cytosolic chemical sensors and respond to threatening
levels of toxic chemicals. The results are the overexpression of MDR
transporters, which promote efflux from cells, thus protecting them
from toxic substances.
Of all known MDR transporters, the Escherichia coli AcrB
multidug efflux pump, which belongs to the resistance–nodulation–
division transporter family, shows the widest substrate specificity,
ranging from most currently used antibiotics, disinfectants, dyes, bile
salts, fatty acids and detergents to simple solvents (Nikaido, 1996;
Zgurskaya & Nikaido, 2000a). This inner membrane efflux pump,
AcrB, interacts with a periplasmic membrane-fusion protein, AcrA
(Zgurskaya & Nikaido, 2000b), and an outer membrane channel,
TolC (Koronakis et al., 2000), to mediate the extrusion of toxic
compounds across both membranes of E. coli.
The AcrABMDR efflux complex (Ma et al., 1995) is regulated by a
global transcriptional activator MarA and a local transcriptional
repressor AcrR (Ma et al., 1996). The acrR gene is located 140 bp
upstream of the acrAB operon and transcribed divergently (Ma et al.,
1996). It encodes a 215-amino-acid protein with a molecular weight of
approximately 25 kDa, which shares sequence and structural simila-
rities to members of the TetR family of transcriptional repressors
(Ramos et al., 2005). Like other members of the TetR family, the
N-terminal domain of AcrR contains a predicted DNA-binding
helix–turn–helix (HTH) motif and its C-terminal domain is predicted
to form a multi-ligand-binding site for its inducing ligands. Sequence
alignment of the N-terminal HTH motif indicates that AcrR shares
28% identity and 61% similarity with TetR (Hinrichs et al., 1994). It
also shows 53% identity and 78% homology to the MtrR repressor
(Hoffmann et al., 2005). Like many other transcriptional regulators,
AcrR can autoregulate its own expression.
The AcrR repressor recognizes a variety of structurally unrelated
toxic compounds and regulates the transcription of the AcrAB
transporter. The hypothesis is that binding of ligands to the
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C-terminal domain of AcrR triggers conformational change in the
N-terminal DNA-binding region. This change in conformation results
in the release of AcrR from its operator DNA and thus allows
transcription from its cognate promoter. As an initial step to eluci-
dating the mechanisms that AcrR uses to recognize multiple ligands
and regulate gene expression, we here report the cloning, expression,
purification and crystallization of the AcrR repressor.
2. Cloning, expression and purification
The ORF of acrR from E. coli K12 chromosomal DNAwas amplified
by PCR using the primers 50-AAACCATGGCACGAAAAACC-
AAAC-30 and 50-AAAGGATCCTTAATGGTGATGGTGATGA-
TGTTCGTTAGTGGCAGGATTAC-30. The resulting product was
cloned into pET15b (Novagen) to generate a recombinant protein
that contains a 6His tag at the C-terminus. Engineered restriction
sites and the 6His-encoding sequence were designed in the primers.
The 680 bp PCR fragment of the acrR gene with flanking sequences
was extracted from the agarose gel using a gel-extraction kit (Qiagen)
and then digested withNcoI and BamHI (New England Biolabs). The
digested products were ligated into the pET15b expression vector.
The recombinant plasmids were transformed into DH5 cells and
selected on LB plates containing 100 mg ml1 ampicillin. The
construction was verified by DNA sequencing.
Native AcrR protein containing a 6His tag at the C-terminus was
overproduced in E. coli BL21(DE3) cells. Briefly, cells from a 5 ml
overnight pre-culture were grown in 500 ml LB broth medium
containing 100 mg ml1 ampicillin at 310 K and 210 rev min1. The
culture was induced with 1 mM isopropyl -d-thiogalactopyranoside
(IPTG) at an OD600 value of approximately 0.5. Cells were harvested
within 4 h of induction and were frozen and stored at 193 K until
further processing.
For producing selenomethionyl-AcrR protein, a 50 ml LB culture
containing 100 mg ml1 ampicillin was grown at 310 K and
210 rev min1. When the OD600 value was around 1.2, cells were
harvested by centrifugation at 6000 rev min1 for 10 min and then
washed two times with 5 ml M9 medium containing 6.8 g l1
Na2HPO4, 3 g l
1 KH2PO4, 0.5 g l
1 NaCl, 4 g l1 glucose, 1 g l1
NH4Cl, 10 ml l
1 Gibco MEM vitamin solution, 1 mM MgSO4 and
0.1 mM CaCl2. The cells were resuspended in 5 ml M9 medium and
then transferred into 500 ml M9 medium containing 100 mg ml1
ampicillin. The cell culture was incubated at 310 K and 210 rev min1.
When the OD600 reached 0.4, 50 mg lysine, phenylalanine and
threonine, 25 mg isoleucine, leucine and valine and 30 mg l-seleno-
methionine were added. The culture was then induced with 1 mM
IPTG after 15 min. Cells were harvested within 4 h and were frozen
and stored at 193 K.
The purification procedures for native AcrR and SeMet-AcrR
were the same. For purification of either the native or SeMet protein,
cells were suspended in 40 ml ice-cold buffer containing 20 mM Na
HEPES pH 7.2 and 200 mM NaCl. The cells were then lysed in a
French pressure cell. Cell debris was removed by centrifugation for
45 min at 277 K and 20 000 rev min1. The crude lysate was filtered
through a 0.2 mm membrane and was loaded onto a 5 ml Hi-Trap
Ni2+-chelating column (Amersham Pharmacia Biosciences) which
was pre-equilibrated with 20 mM Na HEPES pH 7.2 and 200 mM
NaCl. To remove unbound proteins and impurities, the column was
first washed with six column volumes of buffer containing 50 mM
imidazole, 200 mM NaCl and 20 mM Na HEPES pH 7.2. The AcrR
protein was then eluted with four column volume of buffer containing
400 mM imidazole, 200 mMNaCl and 20 mMNa HEPES pH 7.2. The
purity of the protein was judged using 10% SDS–PAGE stained with
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Figure 1
E. coli AcrR crystal. The dimensions of the crystal are approximately 200  100 
100 mm.
Table 1
Data-collection and processing statistics for native and selenomethioninyl-AcrR.
Parameters Native Peak (1) Edge (2) Remote (3)
Wavelength (A˚) 1.0020 0.9816 0.9818 0.9666
Space group P32 P32 P32 P32
Unit-cell parameters (A˚)
a (A˚) 46.61 46.40 46.47 46.51
b (A˚) 46.61 46.40 46.47 46.51
c (A˚) 166.16 166.37 167.75 167.90
Resolution range (A˚) 50–2.49
(2.59–2.49)
50–3.00
(3.11–3.00)
50–3.11
(3.22–3.11)
50–3.23
(3.35–3.23)
Total No. of reflections 471437 1449931 1541643 775457
No. of unique reflections 15849 9037 7281 6497
Rmerge (%) 5.2 (24.7) 9.1 (18.8) 8.1 (19.8) 9.3 (19.9)
Completeness (%) 94.4 (90.0) 98.0 (87.1) 98.0 (87.1) 96.5 (78.4)
Average I/(I) 16.1 (3.9) 15.4 (7.1) 13.2 (3.1) 15.7 (3.1)
Figure 2
X-ray diffraction pattern of the native AcrR crystal. The crystal diffracted beyond a
resolution of 2.5 A˚.
Coomassie Brilliant Blue. The purified protein was extensively
dialyzed against buffer containing 60 mM imidazole, 200 mM NaCl
and 20 mM Tris pH 7.5 and was concentrated to 20 mg ml1. The 215-
amino-acid AcrR contains seven methionines; the replacement of
these methionine sulfurs with seleniums in the SeMet-AcrR protein
was confirmed by MALDI time-of-flight mass spectrometry.
3. Crystallization, data collection and processing
The 6His AcrR protein was crystallized in 24-well plates using the
hanging-drop vapor-diffusion method at 293 K. The initial crystal-
lization screening was performed using commercially available
sparse-matrix screens (Jancarik & Kim, 1991) from Hampton
Research. A 4 ml drop consisting of 2 ml protein solution (20 mg ml1
AcrR in 20 mM Tris pH 7.5, 60 mM imidazole and 200 mMNaCl) and
2 ml well solution was equilibrated against 500 ml well solution.
Crystals appeared within 3 d. After optimization, the best native
6His AcrR crystals were obtained from well solution containing
32% PEG 4000, 0.2M MgCl2 and 0.1M Tris buffer pH 8.5, with
dimensions of about 200  100  100 mm. Fig. 1 illustrates a typical
native crystal of the 6His AcrR. SeMet crystals with approximate
dimensions 120  80  80 mm were obtained from 29% PEG 4000,
0.2M MgCl2 and 0.1M Tris buffer pH 8.5.
For data collection, a single native crystal was flash-cooled in a
cryoprotectant solution containing 35% PEG 4000, 0.2MMgCl2 and
0.1M Tris buffer pH 8.5 at 100 K. The best crystal diffracted to a
maximum resolution of 2.5 A˚ (Table 1). Fig. 2 depicts one of the
diffraction images of the native AcrR crystal. Multiple-wavelength
anomalous diffraction (MAD) data were collected from a single
SeMet-AcrR crystal to a maximum resolution of 3.0 A˚ (Table 1).
Diffraction data sets for both the native and SeMet-AcrR crystals
were obtained at the Advanced Light Source (beamline 8.2.2) at
cryogenic temperature (100 K) on an ADSC Quantum 315 CCD-
based detector. The beam size was 140  150 mm. Diffraction data
sets were processed with DENZO and scaled with SCALEPACK
(Otwinowski & Minor, 1997). The native AcrR crystal belonged to
space group P32, with unit-cell parameters a = b = 46.6, c = 166.2 A˚.
The SeMet-AcrR crystal belonged to the same space group, with very
similar unit-cell parameters (Table 1). Based on the molecular weight
of the protein (25.4 kDa, including the 6His tag at the C-terminus)
and the volume of the asymmetric unit, the Matthews parameters for
one, two and three molecules of AcrR in the asymmetric unit were
found to be 4.1, 2.0 and 1.4 A˚3 Da1, respectively. The available
structures of members of the TetR family of transcriptional repres-
sors, including TetR (Hinrichs et al., 1994; Orth et al., 2000), QacR
(Schumacher et al., 2001, 2002), CprB (Natsume et al., 2003) and
EthR (Dover et al., 2004; Frenois et al., 2004), indicate that all these
repressors assemble as dimers. This suggests the presence of two
AcrR molecules per asymmetric unit, with a solvent content of
39.5%. Analysis of the structure is currently in progress.
We are grateful to Corie Ralston (Advanced Light Source, Lawr-
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